Literature DB >> 15657690

Procalcitonin--a marker of invasive fungal infection?

H J Dornbusch1, V Strenger, R Kerbl, H Lackner, W Schwinger, P Sovinz, C Urban.   

Abstract

Procalcitonin (PCT) has been described as a marker of bacterial sepsis. However, little is known of its diagnostic value in fungal infections. We calculated the sensitivity of PCT for detection of invasive fungal infections (IFI) by analyzing 55 episodes of proven or probable IFI (three in our series, 52 reported in the recent literature). In the early phase of IFI, PCT was elevated in fewer than half of invasive candidiasis episodes and in only one patient (5.3%) with invasive aspergillosis. Due to low sensitivity and specificity, PCT adds little to the diagnosis of IFI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657690     DOI: 10.1007/s00520-004-0721-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  15 in total

Review 1.  Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period.

Authors:  W Oczenski; R D Fitzgerald; S Schwarz
Journal:  Eur J Anaesthesiol       Date:  1998-03       Impact factor: 4.330

2.  Failure of PCT to indicate severe fungal infection in two immunodeficient patients.

Authors:  W Huber; U Schweigart; P Bottermann
Journal:  Infection       Date:  1997 Nov-Dec       Impact factor: 3.553

3.  Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation.

Authors:  Lothar Hambach; Matthias Eder; Elke Dammann; Andreas Schrauder; Karl-Walter Sykora; Christian Dieterich; Philip Kirschner; Jürgen Novotny; Arnold Ganser; Bernd Hertenstein
Journal:  Haematologica       Date:  2002-06       Impact factor: 9.941

4.  Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.

Authors:  M Svaldi; J Hirber; A I Lanthaler; O Mayr; S Faes; E Peer; M Mitterer
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

5.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

6.  Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Authors:  Sofia Christofilopoulou; Ekatherina Charvalos; George Petrikkos
Journal:  Eur J Intern Med       Date:  2002-12       Impact factor: 4.487

7.  Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.

Authors:  G Fleischhack; D Cipic; J Juettner; C Hasan; U Bode
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

8.  Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis.

Authors:  G Beaune; F Bienvenu; C Pondarré; G Monneret; J Bienvenu; G Souillet
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

9.  Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

Authors:  I Delèvaux; M André; M Colombier; E Albuisson; F Meylheuc; R-J Bègue; J-C Piette; O Aumaître
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

10.  Procalcitonin--a sepsis parameter in severe burn injuries.

Authors:  D von Heimburg; W Stieghorst; R Khorram-Sefat; N Pallua
Journal:  Burns       Date:  1998-12       Impact factor: 2.744

View more
  12 in total

1.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

2.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

3.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

5.  Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders.

Authors:  Hans Jürgen Dornbusch; Volker Strenger; Petra Sovinz; Herwig Lackner; Wolfgang Schwinger; Reinhold Kerbl; Christian Urban
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

6.  Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies.

Authors:  Massimo Offidani; Laura Corvatta; Lara Malerba; Maria-Novella Piersantelli; Esther Manso; Pietro Leoni
Journal:  Support Care Cancer       Date:  2006-02-15       Impact factor: 3.603

Review 7.  Utility of blood procalcitonin concentration in the management of cancer patients with infections.

Authors:  Bonita Durnaś; Marzena Wątek; Tomasz Wollny; Katarzyna Niemirowicz; Michał Marzec; Robert Bucki; Stanisław Góźdź
Journal:  Onco Targets Ther       Date:  2016-01-22       Impact factor: 4.147

8.  Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.

Authors:  Andreas Trobisch; R Marterer; G Gorkiewicz; S Flaschberger; H Lackner; M Seidel; D Sperl; A Karastaneva; B Kohlmaier; M Egger; C Urban; M Benesch; V Strenger
Journal:  Support Care Cancer       Date:  2019-08-14       Impact factor: 3.603

9.  Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics.

Authors:  João Manoel Silva; Sigrid De Sousa dos Santos
Journal:  J Int AIDS Soc       Date:  2013-01-30       Impact factor: 5.396

10.  Malignancy and chemotherapy induced haemophagocytic lymphohistiocytosis in children and adolescents-a single centre experience of 20 years.

Authors:  Volker Strenger; Gerald Merth; Herwig Lackner; Stephan W Aberle; Harald H Kessler; Markus G Seidel; Wolfgang Schwinger; Daniela Sperl; Petra Sovinz; Anna Karastaneva; Martin Benesch; Christian Urban
Journal:  Ann Hematol       Date:  2018-02-06       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.